This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.
Get full access to this article
View all access options for this article.
References
1.
DasC., MendezG., JagasiaS., LabbateL.A.Second-generation antipsychotic use in schizophrenia and associated weight gain: A critical review and meta-analysis of behavioral and pharmacologic treatments. Ann Clin Psychiatry.2012; 24(3): 225–239.
2.
FiedorowiczJ.G., MillerD.D., BishopJ.R., CalargeC.A., EllingrodV.L., HaynesW.G.Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers. Curr Psychiatry Rev.2012; 8(1): 25–36.
3.
McElroyS.L., WinstanleyE., MoriN.A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain. J Clin Psychopharmacol.2012; 32(2): 165–172.
4.
GhanizadehA., NiksereshtM.S., SahraianA.The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial. Schizophr Res.2013; 147(1): 110–115.
5.
LimJ., KoY.H., JoeS.H., HanC., LeeM.S., YangJ.Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients. Prog Neuropsychopharmacol Biol Psychiatry.2011; 35(8): 1918–1921.
6.
YangJ., LeeM.S., JoeS.H., JungI.K., KimS.H.Zonisamide-induced weight loss in schizophrenia: Case series. Clin Neuropharmacol.2010; 33(2): 104–106.
7.
MaayanL., VakhrushevaJ., CorrellC.U.Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: A systematic review and meta-analysis. Neuropsychopharmacology.2010; 35(7): 1520–1530.
